NewAmsterdam Pharma Company N.V. NAMS · SEC Filings

website

100

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enha...

Price19

Market Cap2.27 B

Float81.5 M

CountryNL

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Mar 10, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Dec 13, 2024

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Dec 10, 2024

424B5

ATM | Offering amount: $150,000,000

Aug 9, 2024

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Apr 19, 2024

424B3

64,017,688 Ordinary Shares-

Mar 12, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 5, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 18, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Feb 28, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 7, 2025

S-3MEF

Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]

Dec 11, 2024

POS AM

Form POS AM - Post-Effective amendments for registration statement

Aug 9, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 6, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 20, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 8, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 9, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 11, 2025

CORRESP

Form CORRESP - Correspondence

Mar 6, 2025

LETTER

Form UPLOAD - SEC-generated letter

Mar 4, 2025

LETTER

Form UPLOAD - SEC-generated letter

Nov 1, 2024

CORRESP

Form CORRESP - Correspondence

Oct 18, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 30, 2024